Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy.

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Pulmonary Circulation Pub Date : 2024-06-07 eCollection Date: 2024-04-01 DOI:10.1002/pul2.12396

Donna Steinbacher, Brian Murray, Thomas Devlin, Shannon S Carson, H James Ford

引用次数: 0

Abstract

Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life-threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.

查看原文本刊更多论文

与吸入前列环素治疗相关的严重支气管痉挛和急性呼吸衰竭。

前列环素疗法是治疗肺动脉高压（PAH）的主要方法。吸入前列环素是治疗 PAH 的安全有效选择，可限制全身副作用。我们描述了首例与吸入前列环素用药相关的危及生命的支气管痉挛和急性呼吸衰竭病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pulmonary Circulation Medicine-Pulmonary and Respiratory Medicine

CiteScore

4.20

自引率

11.50%

发文量

153

审稿时长

15 weeks

期刊介绍： Pulmonary Circulation''s main goal is to encourage basic, translational, and clinical research by investigators, physician-scientists, and clinicans, in the hope of increasing survival rates for pulmonary hypertension and other pulmonary vascular diseases worldwide, and developing new therapeutic approaches for the diseases. Freely available online, Pulmonary Circulation allows diverse knowledge of research, techniques, and case studies to reach a wide readership of specialists in order to improve patient care and treatment outcomes.